Gonzalo Recondo

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

NPJ precision oncology

JCO precision oncology

Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno

Institut Gustave Roussy École doctorale de cancérologie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno Oct 15 2019

Argentina

Medical Oncologist :: Medical Oncology

Dana Farber Cancer Institute Oct 10 2018

United States

Visiting Scientist :: Medical Oncology- Lowe Center for Thoracic Oncology

Education History

Institut Gustave Roussy École doctorale de cancérologie

France

PHD :: INSERM U981

Universidad de Buenos Aires

Argentina

MSC

Universidad de Buenos Aires Facultad de Medicina

Argentina

PHD

Publications

Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Andrés Felipe Cardona, Camila Ordóñez-Reyes, Alejandro Ruíz-Patiño, Juan Esteban Garcia-Robledo, Lucia Zatarain Barron, Gonzalo Recondo, Leonardo Rojas, Luis Corrales-Rodríguez, Claudio Marcelo Martin, Feliciano Barrón, Carolina Sotelo-Rodríguez, July Rodríguez, Luisa Ricaurte, Christian C Rolfo, Jenny Ávila, Diana Mayorga, Pilar Archila, Jorge Otero, Luis Mas, Maritza Bermudez, Tatiana Gamez, Hernán Carranza, Carlos Vargas, Rafael Rosell, Arrieta Oscar
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP). JCO precision oncology 5 (2022)
Juan Bautista Blaquier, Gonzalo Recondo
Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S. Journal of chemotherapy (Florence, Italy) (2022)
Gonzalo Recondo, Laura Mezquita
Clinical efficacy, predictive biomarkers and response patterns of immunotherapy combinations for patients with cancer. Future oncology (London, England) 16 (23) (2021)
Gonzalo Recondo, Jianwei Che, Pasi A Jänne, Mark M Awad
Targeting MET Dysregulation in Cancer. Cancer discovery 10 (7) (2020)
Gonzalo Recondo, Linda Mahjoubi, Aline Maillard, Yohann Loriot, Ludovic Bigot, Francesco Facchinetti, Rastislav Bahleda, Anas Gazzah, Antoine Hollebecque, Laura Mezquita, David Planchard, Charles Naltet, Pernelle Lavaud, Ludovic Lacroix, Catherine Richon, Aurelie Abou Lovergne, Thierry De Baere, Lambros Tselikas, Olivier Deas, Claudio Nicotra, Maud Ngo-Camus, Rosa L Frias, Eric Solary, Eric Angevin, Alexander Eggermont, Ken A Olaussen, Gilles Vassal, Stefan Michiels, Fabrice Andre, Jean-Yves Scoazec, Christophe Massard, Jean-Charles Soria, Benjamin Besse, Luc Friboulet
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy. NPJ precision oncology 4 (2020)
Biagio Ricciuti, Gonzalo Recondo, Liam F Spurr, Yvonne Y Li, Giuseppe Lamberti, Deepti Venkatraman, Renato Umeton, Andrew D Cherniak, Mizuki Nishino, Lynette M Sholl, Geoffrey I Shapiro, Mark M Awad, Michael L Cheng
Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)
Gonzalo Recondo, Magda Bahcall, Liam F Spurr, Jianwei Che, Biagio Ricciuti, Giulia C Leonardi, Ying-Chun Lo, Yvonne Y Li, Giuseppe Lamberti, Tom Nguyen, Marina S D Milan, Deepti Venkatraman, Renato Umeton, Cloud P Paweletz, Adem Albrayak, Andrew D Cherniack, Kristin S Price, Stephen R Fairclough, Mizuki Nishino, Lynette M Sholl, Geoffrey R Oxnard, Pasi A Jänne, Mark M Awad
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Maria Virginia Bluthgen, Neus Basté, Gonzalo Recondo
Immunotherapy combinations for the treatment of patients with solid tumors. Future oncology (London, England) 16 (23) (2020)
Gonzalo Recondo, Linda Mahjoubi, Aline Maillard, Yohann Loriot, Ludovic Bigot, Francesco Facchinetti, Rastislav Bahleda, Anas Gazzah, Antoine Hollebecque, Laura Mezquita, David Planchard, Charles Naltet, Pernelle Lavaud, Ludovic Lacroix, Catherine Richon, Aurelie Abou Lovergne, Thierry De Baere, Lambros Tselikas, Olivier Deas, Claudio Nicotra, Maud Ngo-Camus, Rosa L Frias, Eric Solary, Eric Angevin, Alexander Eggermont, Ken A Olaussen, Gilles Vassal, Stefan Michiels, Fabrice Andre, Jean-Yves Scoazec, Christophe Massard, Jean-Charles Soria, Benjamin Besse, Luc Friboulet
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy. NPJ precision oncology 4 (1) (2020)
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z Rizvi, Rosa L Frias, Jean-Paul Thiery, Jean-Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Deas, Dariia Samofalova, Justine Galissant, Pauline Tesson, Floriane Braye, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, Claudio Nicotra, Maud Ngo-Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry De Baere, Lambros Tselikas, Eric Solary, Eric Angevin, Alexander M Eggermont, Fabrice Andre, Christophe Massard, Ken A Olaussen, Jean-Charles Soria, Benjamin Besse, Luc Friboulet
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (1) (2019)

Gonzalo Recondo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gonzalo Recondo